about
Nucleoside and RNA triphosphatase activities of orthoreovirus transcriptase cofactor mu2Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolatesReovirus core protein mu2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules.The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptorVirus-mediated compartmentalization of the host translational machinery.Molecular virology of feline calicivirus.The cellular chaperone hsc70 is specifically recruited to reovirus viral factories independently of its chaperone function.Micro-total analysis system for virus detection: microfluidic pre-concentration coupled to liposome-based detection.Reovirus infection or ectopic expression of outer capsid protein micro1 induces apoptosis independently of the cellular proapoptotic proteins Bax and Bak.Increased ubiquitination and other covariant phenotypes attributed to a strain- and temperature-dependent defect of reovirus core protein mu2.Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection.The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry.Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus.Distribution of the feline calicivirus receptor junctional adhesion molecule a in feline tissues.Conserved surface residues on the feline calicivirus (FCV) capsid are essential for interaction with its receptor feline junctional adhesion molecule A (fJAM-A).Bacterial filtration efficiency of green soy protein based nanofiber air filter.Mammalian orthoreovirus Infection is Enhanced in Cells Pre-Treated with Sodium Arsenite
P50
Q28183799-BCB2021D-3BCD-4F9D-BB15-3C3E20791ECCQ28284951-4B6C4FD3-0667-4C60-AB96-42FC75A962FBQ34122036-0D582D4C-660E-40B0-BDED-15877A6A417DQ34170231-4CF36063-52BD-4424-B419-09309930B7ABQ34229838-F3D473C4-E9E3-4AB5-878B-DBEB5F0219D7Q37172218-F89DDC82-588D-4738-AF58-5AC40DB778E5Q39441933-653752FE-D617-40A7-8F1D-9570BEC4092CQ39475763-19DF6349-D419-4E2C-814C-775ADF5DDCB2Q39639146-7337650F-7F68-41E4-A121-E4144EA231F2Q39991940-616732BB-F7A6-4469-97A9-F8C15DE183CEQ40072519-657E6C4B-A125-4200-B58E-916E650DBEC5Q40344603-8960AACE-9A14-46BD-ABB1-1DA003CEA704Q40530759-CC245550-FCEF-4F9A-BEBE-18D35BB551CBQ46170662-06A32ADA-30C9-4F8F-ADC2-B710822D776FQ47547472-42B35A94-85F2-4A68-9F85-79EF5B914A61Q50457294-049BE6FB-A6DD-4D90-A7C8-5F8BF64A5C6EQ92879458-2FDC07F7-BE7B-46DA-8BFB-DC14FB645F85
P50
description
researcher
@en
wetenschapper
@nl
name
John S L Parker
@en
John S L Parker
@nl
type
label
John S L Parker
@en
John S L Parker
@nl
prefLabel
John S L Parker
@en
John S L Parker
@nl
P108
P106
P31
P496
0000-0003-4487-4175